Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis
- PMID: 20696064
- PMCID: PMC2924267
- DOI: 10.1186/1471-2466-10-42
Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis
Abstract
Background: We assessed the relationship between physiologic parameters, computed tomography patterns, 6 minute walk distance (6MWD) and the distance-saturation product [DSP; defined as the product of the 6MWD and the lowest oxygen saturation during the 6 minute walk test (6MWT)]. In addition, we investigated factors affecting 6MWD in patients with pulmonary sarcoidosis.
Methods: We performed a retrospective study of patient demographics, treatment, pulmonary function, 6MWT, echocardiography and computed tomography results.
Results: Fifty nine patients were included in this study. Their mean+standard deviation age was 47.5 years + 12.5 years, and 42 (71.2%) were female. Mean pulmonary function parameters for forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1) and total lung capacity (TLC) results, as percentages of predicted values, were 77.6 +/- 22.2, 77.1 +/- 22.8 and 78.7 +/- 16.1, respectively. Comparison of the DSP with distance walked revealed a significant correlation with factors underlying reduced 6MWD, including gender, pulmonary function indices, partial pressure of oxygen (PaO2), and Borg dyspnea score. Other factors were significantly associated with DSP but not distance; these included lung fibrosis (p = 0.02), pulmonary hypertension (p = 0.01) and systemic therapy (p = 0.04). Backward elimination stepwise multiple regression analysis revealed that gender, and FEV1 were independent predictors of 6MWD, but FEV1 was more strongly related when DSP applied [DSP, R2 = 0.53, p = 0.02; distance, R2 = 0.45, p < 0.0001].
Conclusion: Our findings reveal that, compared to 6MWD alone, the DSP is correlated with a greater number of factors associated with reduced 6MWT performance. Therefore, the DSP may be a useful indicator of functional status in patients with sarcoidosis. Additional large-scale studies are warranted to validate our findings.
Similar articles
-
Six-minute walk test and health status assessment in sarcoidosis.Chest. 2007 Jul;132(1):207-13. doi: 10.1378/chest.06-2822. Chest. 2007. PMID: 17625083
-
Pulmonary function test results are correlated with 6-minute walk distance, distance-saturation product, and 6-minute walk work in patients with lymphangioleiomyomatosis.Respir Med Res. 2024 Jun;85:101071. doi: 10.1016/j.resmer.2023.101071. Epub 2023 Nov 28. Respir Med Res. 2024. PMID: 38141576
-
The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.Respir Med. 2022 May;196:106801. doi: 10.1016/j.rmed.2022.106801. Epub 2022 Mar 16. Respir Med. 2022. PMID: 35316723
-
The Short- and Long-Term Impact of Pulmonary Rehabilitation in Subjects with Sarcoidosis: A Prospective Study and Review of the Literature.Respiration. 2021;100(5):423-431. doi: 10.1159/000514917. Epub 2021 Mar 30. Respiration. 2021. PMID: 33784708 Review.
-
Clinical utility of the Borg dyspnoea score in 6-minute walk tests in interstitial lung disease: A systematic review.Respir Med Res. 2024 Jun;85:101103. doi: 10.1016/j.resmer.2024.101103. Epub 2024 Mar 19. Respir Med Res. 2024. PMID: 38663251
Cited by
-
Patient reported outcome measures (PROMs) in sarcoidosis.Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):2-17. doi: 10.36141/svdld.v34i1.5760. Epub 2017 Apr 28. Sarcoidosis Vasc Diffuse Lung Dis. 2017. PMID: 32476819 Free PMC article. Review.
-
Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease in comparison with idiopathic interstitial pneumonia.Clin Med Insights Circ Respir Pulm Med. 2013;7:1-6. doi: 10.4137/CCRPM.S10764. Epub 2013 Jan 22. Clin Med Insights Circ Respir Pulm Med. 2013. PMID: 23400027 Free PMC article.
-
Longitudinal significance of six-minute walk test in patients with nontuberculous mycobacterial pulmonary disease: an observational study.BMC Pulm Med. 2023 Jul 6;23(1):247. doi: 10.1186/s12890-023-02528-y. BMC Pulm Med. 2023. PMID: 37415094 Free PMC article.
-
Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis.Lung. 2011 Oct;189(5):425-31. doi: 10.1007/s00408-011-9316-1. Epub 2011 Aug 20. Lung. 2011. PMID: 21858420
-
Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction?: A case-control study.Medicine (Baltimore). 2019 Nov;98(47):e18037. doi: 10.1097/MD.0000000000018037. Medicine (Baltimore). 2019. PMID: 31764823 Free PMC article.
References
-
- Costabel U. Sarcoidosis: clinical update. Eur Respir J Suppl. 2001;32:56s–68s. - PubMed
-
- Hansell DM, Milne DG, Wilsher ML, Wells AU. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology. 1998;209(3):697–704. - PubMed
-
- Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology. 1994;191(3):675–680. - PubMed
-
- Remy-Jardin M, Giraud F, Remy J, Copin MC, Gosselin B, Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology. 1993;189(3):693–698. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous